IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 7 analysts with an average price target of $39.68. This is a potential upside of $13.65 (52.44%) from yesterday's end of day stock price of $26.03.

Immunovant 's activity chart (see below) currently has 147 price targets and 114 ratings on display. The stock rating distribution of IMVT is 86.67% BUY and 13.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.27% with an average time for these price targets to be met of 179.17 days.

Highest price target for IMVT is $61, Lowest price target is $16, average price target is $32.

Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 14-Oct-2025. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 13 are a BUY (86.67%), 2 are a HOLD (13.33%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 14-Oct-2025

$16

$-9.91 (-38.25%)

$36

2 months 26 days ago
(14-Oct-2025)

2/4 (50%)

$-1.49 (-8.52%)

35

Buy

Since 20-Feb-2024

$33

$7.09 (27.36%)

$37

3 months 10 days ago
(30-Sep-2025)

0/4 (0%)

$16.88 (104.71%)

Buy

Since 29-Jul-2020

$35

$9.09 (35.08%)

$51

4 months 5 days ago
(04-Sep-2025)

11/21 (52.38%)

$18.88 (117.12%)

268

Buy

Since 23-May-2023

$30

$4.09 (15.79%)

$33

4 months 28 days ago
(12-Aug-2025)

1/4 (25%)

$14.79 (97.24%)

126

Hold

Since 22-Apr-2025

$17

$-8.91 (-34.39%)

$41

8 months 18 days ago
(22-Apr-2025)

2/6 (33.33%)

$2.75 (19.30%)

41

Show more analysts

Please expand the browser size to see the chart

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 179.17 days on average for the stock forecasts to be realized with a an average price target met ratio 59.27

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

GBOLA AMUSA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Gbola Amusa has 5 price targets and 5 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Alex Thompson with highest potential upside - $35.09

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$18.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?